Five (un)easy pieces: The MYH9-related giant platelet syndromes

Haematologica

Volumn 87, Issue 9, 2002, Pages 897-898

  Martignetti, John ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; GLYCOPROTEIN IB; MYOSIN HEAVY CHAIN;

ALPORT SYNDROME; AUTOSOMAL DOMINANT DISORDER; BERNARD SOULIER DISEASE; BLEEDING DISORDER; CATARACT; CELL INTERACTION; CELL MATURATION; CHROMOSOMAL LOCALIZATION; COMPLEX FORMATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; HEARING IMPAIRMENT; HUMAN; MAY HEGGLIN ANOMALY; NEPHRITIS; NOTE; PATHOGENESIS; PHENOTYPE; THROMBOCYTE ANOMALY; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; X CHROMOSOME LINKAGE;

BERNARD-SOULIER SYNDROME; BLOOD PLATELETS; HUMANS; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS;

EID: 0036739756     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (16)

1. Kaushansky K, Drachman JG. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene 2002; 21:3359-67.
2. Weich NS, Fitzgerald M, Wang A, Calvetti J, Yetz-Aldape J, Neben S, et al. Recombinant human interleukin-11 synergizes with steel factor and interleukin-3 to promote directly the early stages of murine megakaryocyte development in vitro. Blood 2000; 95:503-9.
3. Rojnuckarin P, Kaushansky K. Actin reorganization and proplatelet formation in murine megakaryocytes: the role of protein kinase cα. Blood 2001; 97:154-61.
4. Shivdasani RA. Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells 2001; 19: 397-407.
5. Bernard J, Soulier JP. Sur une nouvelle variete de dystrophie thrombocytaire-hemoragipare congenitale. Semin Hop Paris 1948; 24:3217-23.
6. DiPumpo D, Noris P, Pecci A, Savoia A, Seri M, Ceresa IF, et al. Defective expression of GPIb/IX/V complex in platelets from patients with May-Hegglin anomaly and Sebastain syndrome. Haematologica 2002; 87:943-7.
7. May R. Leukozyteneinschlusse. Dtsch Arch Klin Med 1909; 96:1-6.
8. Toren A, Amariglio N, Rozenfeld-Granot G, Simon AJ, Brok-Simoni F, Pras E, et al. Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13. Am J Hum Genet 1999; 65:1711-7.
9. Kunishima S, Kojima T, Tanaka T, Kamiya T, Ozawa K, Nakamura Y, et al. Mapping of a gene for May-Hegglin anomaly to chromosome 22q. Hum Genet 1999; 105:379-83.
10. Martignetti JA, Heath KE, Harris J, Bizzaro N, Savoia A, Balduini CL, et al. The gene for May-Hegglin anomaly localizes to a <1-Mb region on chromosome 22q12.3-13.1. Am J Hum Genet 2000; 66:1449-54.
11. Cusano R, Gangarossa S, Forabosco P, Caridi G, Ghiggeri GM, Russo G, et al. Localisation of the gene responsible for Fechtner syndrome in a region <600 Kb on 22q11-q13. Eur J Hum Genet 2000; 8:895-9.
12. Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo Nigro C, et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. Nat Genet 2000; 26:103-5.
13. Kelley MJ, Jawien W, Ortel TL, Korczak JF. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet 2000; 26:106-8.
14. Heath KE, Campos-Barros A, Toren A, Rozenfeld-Granot G, Carlsson LE, Savige J, et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 2001; 69:1033-45.
15. Kunishima S, Matsushita T, Kojima T, Amemiya N, Choi YM, Hosaka N, et al. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions. J Hum Genet 2001; 46:722-9.
16. Sellers JR. Myosins: a diverse superfamily. Biochim Biophys Acta 2000; 1496:3-22.